BC logo_white.png

BUILDING PATHWAYS TO PATIENTS 

FOR INFORMATION ON COVID-19 TESTS PLEASE CLICK BELOW

Blood Samples

US FDA Approves ARAKODA (tafenoquine) tablets for oral use, first preventative antimalarial approved in almost two decades

21st August, 2018

Thanks for submitting!

                               CONTACT US

For help or more information,  please don't hesitate to contacts us:

Registered Australian Office:

Biocelect Pty Ltd

Level 4, 51 Rawson Street, Epping NSW 2121, Australia

Registered New Zealand Office:

Biocelect New Zealand Limited

Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

General Inquiries: 1300 907 411 

To report a suspected side effect by a Biocelect
Pharmaceutical Drug or Vaccine: 1300 848 628

  • LinkedIn Social Icon